139 related articles for article (PubMed ID: 12188263)
21. Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging.
Goldbrunner RH; Bendszus M; Sasaki M; Kraemer T; Plate KH; Roosen K; Tonn JC
Neurosurgery; 2000 Oct; 47(4):921-9; discussion 929-30. PubMed ID: 11014432
[TBL] [Abstract][Full Text] [Related]
22. Functional response of tumor vasculature to PaCO2: determination of total and microvascular blood volume by MRI.
Packard SD; Mandeville JB; Ichikawa T; Ikeda K; Terada K; Niloff S; Chiocca EA; Rosen BR; Marota JJ
Neoplasia; 2003; 5(4):330-8. PubMed ID: 14511404
[TBL] [Abstract][Full Text] [Related]
23. Regulation of angiogenesis in malignant gliomas.
Guerin C; Laterra J
EXS; 1997; 79():47-64. PubMed ID: 9002220
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis in human gliomas: prognostic and therapeutic implications.
Johnson JP; Bruce JN
EXS; 1997; 79():29-46. PubMed ID: 9002219
[No Abstract] [Full Text] [Related]
25. Dynamic susceptibility contrast MRI of gliomas.
Aronen HJ; Perkiö J
Neuroimaging Clin N Am; 2002 Nov; 12(4):501-23. PubMed ID: 12687908
[TBL] [Abstract][Full Text] [Related]
26. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.
Rubenstein JL; Kim J; Ozawa T; Zhang M; Westphal M; Deen DF; Shuman MA
Neoplasia; 2000; 2(4):306-14. PubMed ID: 11005565
[TBL] [Abstract][Full Text] [Related]
27. Models for assessment of angiogenesis in gliomas.
Goldbrunner RH; Wagner S; Roosen K; Tonn JC
J Neurooncol; 2000; 50(1-2):53-62. PubMed ID: 11245281
[TBL] [Abstract][Full Text] [Related]
28. Microvascular adaptive changes in experimental endogenous brain gliomas.
Bulnes S; Bilbao J; Lafuente JV
Histol Histopathol; 2009 Jun; 24(6):693-706. PubMed ID: 19337968
[TBL] [Abstract][Full Text] [Related]
29. PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
Goldbrunner RH; Bendszus M; Wood J; Kiderlen M; Sasaki M; Tonn JC
Neurosurgery; 2004 Aug; 55(2):426-32; discussion 432. PubMed ID: 15271251
[TBL] [Abstract][Full Text] [Related]
30. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
Jain R
NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
Plate KH; Breier G; Weich HA; Risau W
Nature; 1992 Oct; 359(6398):845-8. PubMed ID: 1279432
[TBL] [Abstract][Full Text] [Related]
32. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
[TBL] [Abstract][Full Text] [Related]
33. In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice.
Abramovitch R; Dafni H; Smouha E; Benjamin LE; Neeman M
Cancer Res; 1999 Oct; 59(19):5012-6. PubMed ID: 10519416
[TBL] [Abstract][Full Text] [Related]
34. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.
Roberts HC; Roberts TP; Brasch RC; Dillon WP
AJNR Am J Neuroradiol; 2000 May; 21(5):891-9. PubMed ID: 10815665
[TBL] [Abstract][Full Text] [Related]
35. Increased levels of tissue endostatin in human malignant gliomas.
Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
[TBL] [Abstract][Full Text] [Related]
36. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?
Graziano F; Cascinu S
J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535
[No Abstract] [Full Text] [Related]
37. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
[TBL] [Abstract][Full Text] [Related]
38. Vascularization of human glioma spheroids implanted into rat cortex is conferred by two distinct mechanisms.
Goldbrunner RH; Bernstein JJ; Plate KH; Vince GH; Roosen K; Tonn JC
J Neurosci Res; 1999 Feb; 55(4):486-95. PubMed ID: 10723058
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts.
Strugar JG; Criscuolo GR; Rothbart D; Harrington WN
J Neurosurg; 1995 Oct; 83(4):682-9. PubMed ID: 7674019
[TBL] [Abstract][Full Text] [Related]
40. Delayed vascular changes after antiangiogenic therapy with antivascular endothelial growth factor antibodies in human glioma xenografts in nude mice.
Bernsen HJ; Rijken PF; Peters JP; Bakker H; van der Kogel AJ
Neurosurgery; 1998 Sep; 43(3):570-5; discussion 575-6. PubMed ID: 9733312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
